Literature DB >> 14635996

Status of the "protein kinase CK2-HMG14" system in age-related amnesia in rats.

B A Reikhardt1, O G Kulikova, G Yu Borisova, I Ya Aleksandrova, N S Sapronov.   

Abstract

The experiments described here demonstrate that disruption of the phosphorylation of transcription factors of the HMG cAMP/Ca-independent protein kinase CK2 class may be the cause of decreased gene expression in age-related cognitive deficits. Amnesia for a conditioned passive avoidance reaction (CPAR) in aged rats (24 months old) was accompanied by decreases in the synthesis of synaptosomal proteins and transcription in nuclei isolated from cortical, hippocampal, and striatal neurons. There was a decrease in chromatin protein kinase CK2 activity and a significant decrease in the phosphorylation of HMG14 by protein kinase CK2. Selective activators of protein kinase CK2 (1-ethyl-4-carbamoyl-5-methylcarbamoylimidazole and 1-ethyl-4,5-dicarbamoylimidazole) increased HMG14 phosphorylation by protein kinase CK2, increased transcription, increased the synthesis of synaptosomal proteins, and decreased amnesia for the CPAR in aged rats. Thus, activation of the "protein kinase CK2-HMG14" system is accompanied by optimization of synaptic plasticity in aged animals. The results provide evidence for the high therapeutic potential of protein kinase CK2 activators.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14635996     DOI: 10.1023/a:1025101516128

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  21 in total

Review 1.  Specificity of molecular changes in neurons involved in memory storage.

Authors:  D L Alkon; T J Nelson
Journal:  FASEB J       Date:  1990-04-01       Impact factor: 5.191

Review 2.  [High mobility group proteins: structure, localization, function].

Authors:  N A Fedorova
Journal:  Biokhimiia       Date:  1991-01

3.  [The participation of RNA synthesis in the process of the acquisition and retention of conditioned reflexes (a study using antifeins)].

Authors:  O G Kulikova; L M Beliavtseva; G Iu Borisova; I Ia Aleksandrova; Iu S Borodkin
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  1992 Jul-Aug       Impact factor: 0.437

4.  Neurotrophin-induced activation of casein kinase 2 in rat hippocampal slices.

Authors:  P R Blanquet
Journal:  Neuroscience       Date:  1998-10       Impact factor: 3.590

Review 5.  Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation.

Authors:  J E Allende; C C Allende
Journal:  FASEB J       Date:  1995-03       Impact factor: 5.191

Review 6.  Protein kinase CK2.

Authors:  L A Pinna
Journal:  Int J Biochem Cell Biol       Date:  1997-04       Impact factor: 5.085

7.  [The participation of the genetic apparatus in the mechanisms of memory trace formation: the role of the calcium-regulatory system of the neurons in rats].

Authors:  O G Kulikova; B A Reĭkhardt; N S Sapronov
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  1997 Jul-Aug       Impact factor: 0.437

8.  Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain.

Authors:  K Yasojima; J Kuret; A J DeMaggio; E McGeer; P L McGeer
Journal:  Brain Res       Date:  2000-05-19       Impact factor: 3.252

Review 9.  Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy.

Authors:  L W Jin; T Saitoh
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

10.  Rapid activation of hippocampal casein kinase II during long-term potentiation.

Authors:  C Charriaut-Marlangue; S Otani; C Creuzet; Y Ben-Ari; J Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

View more
  6 in total

1.  Protein kinase CK2 is a central regulator of topoisomerase I hyperphosphorylation and camptothecin sensitivity in cancer cell lines.

Authors:  Keya Bandyopadhyay; Ruth A Gjerset
Journal:  Biochemistry       Date:  2011-01-12       Impact factor: 3.162

2.  Hemoglobin neurotoxicity is attenuated by inhibitors of the protein kinase CK2 independent of heme oxygenase activity.

Authors:  Jing Chen-Roetling; Zhi Li; Raymond F Regan
Journal:  Curr Neurovasc Res       Date:  2008-08       Impact factor: 1.990

3.  Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells.

Authors:  Euphemia Leung; Gordon W Rewcastle; Wayne R Joseph; Rhonda J Rosengren; Lesley Larsen; Bruce C Baguley
Journal:  Invest New Drugs       Date:  2011-11-22       Impact factor: 3.850

4.  Phosphorylation of CRN2 by CK2 regulates F-actin and Arp2/3 interaction and inhibits cell migration.

Authors:  Charles-Peter Xavier; Raphael H Rastetter; Margit Blömacher; Maria Stumpf; Mirko Himmel; Reginald O Morgan; Maria-Pilar Fernandez; Conan Wang; Asiah Osman; Yoshihiko Miyata; Ruth A Gjerset; Ludwig Eichinger; Andreas Hofmann; Stefan Linder; Angelika A Noegel; Christoph S Clemen
Journal:  Sci Rep       Date:  2012-01-31       Impact factor: 4.379

5.  The p14ARF alternate reading frame protein enhances DNA binding of topoisomerase I by interacting with the serine 506-phosphorylated core domain.

Authors:  Keya Bandyopadhyay; Pingchuan Li; Ruth A Gjerset
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

6.  CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA binding, and increases cellular camptothecin sensitivity.

Authors:  Keya Bandyopadhyay; Pingchuan Li; Ruth A Gjerset
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.